Pharmacokinetics and Efficacy of the Spleen Tyrosine Kinase Inhibitor R406 after Ocular Delivery for Retinoblastoma

PURPOSE: Retinoblastoma is a childhood cancer of the retina. Clinical trials have shown that local delivery of broad spectrum chemotherapeutic agents is efficacious. Recent studies characterizing the genomic and epigenomic landscape of retinoblastoma identified spleen tyrosine kinase (SYK) as a prom...

Descripción completa

Detalles Bibliográficos
Autores principales: Pritchard, Eleanor M., Stewart, Elizabeth, Zhu, Fangyi, Bradley, Cori, Griffiths, Lyra, Yang, Lei, Suryadevara, Praveen Kumar, Zhang, Jiakun, Freeman, Burgess B., Guy, R. Kiplin, Dyer, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213378/
https://www.ncbi.nlm.nih.gov/pubmed/24906597
http://dx.doi.org/10.1007/s11095-014-1399-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213378/
https://www.ncbi.nlm.nih.gov/pubmed/24906597
http://dx.doi.org/10.1007/s11095-014-1399-y

Ejemplares similares